• Whopping Mortality Benefit in Severe COVID Trial By MedPageToday   -   Jul 7, 2022

    WHOPPING MORTALITY BENEFIT IN SEVERE COVID TRIAL

    Treatment with a novel, oral microtubule disruptor significantly reduced the risk of death in hospitalized COVID-19 patients with severe...

    Hospital
  • Lubricant Shots for Knee OA: No, They Really Don't Help By MedPageToday   -   Jul 7, 2022

    LUBRICANT SHOTS FOR KNEE OA: NO, THEY REALLY DON'T HELP

    Researchers analyzing previous trials of hyaluronic acid injections for knee osteoarthritis found that, although measurable benefit...

    Hyaluronic Acid, Injections, Injection, Osteoarthritis, Knees
  • CEND-1 Offers Hope in Advanced Pancreatic Cancer By MedPageToday   -   Jul 7, 2022

    CEND-1 OFFERS HOPE IN ADVANCED PANCREATIC CANCER

    Chemotherapy combined with the CEND-1 cyclic peptide showed promising efficacy, and was well tolerated as a first-line treatment, for...

    Cancer
  • Fewer Complications With Robotic Nephrectomy in Complex Kidney Tumors By MedPageToday   -   Jul 7, 2022

    FEWER COMPLICATIONS WITH ROBOTIC NEPHRECTOMY IN COMPLEX KIDNEY TUMORS

    Robotic-assisted partial nephrectomy led to a lower rate of complications compared with open partial nephrectomy in patients with intermediate-...

    Tumors
  • Memoirs of a 'Recovering' Peer Reviewer By MedPageToday   -   Jul 7, 2022

    MEMOIRS OF A 'RECOVERING' PEER REVIEWER

    In theory, the application of evidenced-based guidelines assists in reducing unwarranted variation in clinical practice and improving...

    Plan
  • FDA Getting Tougher on Birth Tissue Companies By MedPageToday   -   Jul 7, 2022

    FDA GETTING TOUGHER ON BIRTH TISSUE COMPANIES

    The FDA may be getting tougher on birth tissue injection companies, experts in stem cells and regenerative medicine said. In its most...

    Injections, Injection
  • Bust for Balovaptan in Treatment of Childhood Autism By MedPageToday   -   Jul 7, 2022

    BUST FOR BALOVAPTAN IN TREATMENT OF CHILDHOOD AUTISM

    An oral selective vasopressin 1a receptor antagonist failed at improving socialization and communication among those with pediatric...

  • People With Gum Disease Are More Prone to Heart Failure By MedPageToday   -   Jul 7, 2022

    PEOPLE WITH GUM DISEASE ARE MORE PRONE TO HEART FAILURE

    The link between periodontal disease and heart failure was reinforced by long-term data from the Atherosclerosis Risk in Communities...

  • Anti-LAG-3, Pembrolizumab Doublet Continues to Impress in Metastatic NSCLC By MedPageToday   -   Jul 7, 2022

    ANTI-LAG-3, PEMBROLIZUMAB DOUBLET CONTINUES TO IMPRESS IN METASTATIC NSCLC

    At the recent American Society of Clinical Oncology annual meeting, updated results of a phase II trial showed that the lymphocyte...

  • Hypothyroidism May Predict Dementia in Golden Years By MedPageToday   -   Jul 7, 2022

    HYPOTHYROIDISM MAY PREDICT DEMENTIA IN GOLDEN YEARS

    Older people with a history of hypothyroidism may be at a much higher risk for developing dementia, a Taiwanese study found. Among...

  • T1D Stem Cell Trial Back On; Fifth Grade Obesity; Islet Autoantibodies Predictive By MedPageToday   -   Jul 7, 2022

    T1D STEM CELL TRIAL BACK ON; FIFTH GRADE OBESITY; ISLET AUTOANTIBODIES PREDICTIVE

    After being hit with a clinical hold, Vertex Pharmaceuticals announced it's been given the FDA green-light to push forward on its phase...

    Obesity, Diabetes
  • Promising New Depression Tx; Racially Skewed ADHD Dx; Effective Clozapine Monitoring By MedPageToday   -   Jul 7, 2022

    PROMISING NEW DEPRESSION TX; RACIALLY SKEWED ADHD DX; EFFECTIVE CLOZAPINE MONITORING

    The FDA gave ANeuroTech positive feedback during a pre-investigational new drug meeting on the phase IIIb clinical program testing...

    Drugs, Depression
  • FDA Gives Pharmacists Thumbs Up for Paxlovid Prescribing By MedPageToday   -   Jul 7, 2022

    FDA GIVES PHARMACISTS THUMBS UP FOR PAXLOVID PRESCRIBING

    Licensed pharmacists can now prescribe nirmatrelvir-ritonavir for COVID-19 patients at high risk of progressing to severe disease ,...

  • ASCO 2032: What Will Be the Big Story in Lung Cancer? By MedPageToday   -   Jul 7, 2022

    ASCO 2032: WHAT WILL BE THE BIG STORY IN LUNG CANCER?

    New clinical research unveiled at the recent American Society of Clinical Oncology annual meeting has the potential to significantly...

    Cancer
  • Here's How Many U.S. Deaths COVID Vaccines Prevented By MedPageToday   -   Jul 7, 2022

    HERE'S HOW MANY U.S. DEATHS COVID VACCINES PREVENTED

    The U.S. COVID-19 vaccination program prevented millions of infections as well as hundreds of thousands of deaths, according to a modeling...

    Vaccination
  • FLCCC Co-Founder's Medical License Expires By MedPageToday   -   Jul 7, 2022

    FLCCC CO-FOUNDER'S MEDICAL LICENSE EXPIRES

    Paul Marik, MD, one of the founding members of the Front Line COVID-19 Critical Care Alliance , which has touted ivermectin as a treatment...

  • Prenatal Exposure to Everyday Chemicals Tied to Liver Injury in Kids By MedPageToday   -   Jul 7, 2022

    PRENATAL EXPOSURE TO EVERYDAY CHEMICALS TIED TO LIVER INJURY IN KIDS

    Prenatal environmental exposure to endocrine-disrupting chemicals was associated with a higher risk for liver injury in children, a...

    Child
  • Hey Siri: Is Health Info From Voice Assistants Accurate? By MedPageToday   -   Jul 7, 2022

    HEY SIRI: IS HEALTH INFO FROM VOICE ASSISTANTS ACCURATE?

    All voice assistants are not created equal, at least not when it comes to providing their users with helpful and correct medical information. Cases...

    Cancer
  • Doc Who Pushed HCQ Dies; Fauci's Final Pandemic; Will Abortion Bans Restrict IVF? By MedPageToday   -   Jul 7, 2022

    DOC WHO PUSHED HCQ DIES; FAUCI'S FINAL PANDEMIC; WILL ABORTION BANS RESTRICT IVF?

    Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Doctor...

    Abortion
  • Which Biologics Stick Longest for Psoriasis? By MedPageToday   -   Jul 7, 2022

    WHICH BIOLOGICS STICK LONGEST FOR PSORIASIS?

    Patients stayed longer with guselkumab for psoriasis treatment than any other biologic drug, while adalimumab was dropped the quickest,...

    Drugs, Drop, Registry